Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries.
Pereira FMT, Silva AGE, Dettino ALA, Cardoso APG, Sasse AD, Kann AG, Dzik C, Herchenhorn D, Jardim DLF, Lopera D, Ayadi M, Salman P, Kopp RAM, De Carvalho RS, Cavallero SRA, Aguiar S, Souza VC, Uson Junior PLS, Soares A. Pereira FMT, et al. Among authors: herchenhorn d. JCO Glob Oncol. 2021 Apr;7:545-549. doi: 10.1200/GO.20.00507. JCO Glob Oncol. 2021. PMID: 33856892 Free PMC article.
First Brazilian Consensus of Advanced Prostate Cancer: Recommendations for Clinical Practice.
Sasse AD, Wiermann EG, Herchenhorn D, Bastos DA, Schutz FA, Maluf FC, Coura G Filho, Morbeck IAP, Cerci JJ, Smaletz O, Lima VS, Adamy A Jr, Campos FS, Carvalhal GF, Cezar LC, Dall'Oglio MF, Sadi MV, Reis RBD, Nogueira L. Sasse AD, et al. Among authors: herchenhorn d. Int Braz J Urol. 2017 May-Jun;43(3):407-415. doi: 10.1590/S1677-5538.IBJU.2016.0490. Int Braz J Urol. 2017. PMID: 28199075 Free PMC article.
Second brazilian consensus on the treatment of advanced prostate cancer - a SBOC-SBU-SBRT panel review.
Sasse AD, Dos Reis RB, Nogueira LM, Maluf FC, Herchenhorn D, Smaletz O, Lima VS, Schutz F, Bastos D, Wiermann EG, Morbeck IAP, Jardim LF, Souza VC, Carvalho IT, Leite ETT, Nardozza A Jr, Pompeo ACL, Bretas F, Leal MLO, Sadi MV, da Ponte JRT, Carvalhal GF. Sasse AD, et al. Among authors: herchenhorn d. Int Braz J Urol. 2019 May-Jun;45(3):449-458. doi: 10.1590/S1677-5538.IBJU.2018.0798. Int Braz J Urol. 2019. PMID: 31038861 Free PMC article.
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
Sternberg CN, Fizazi K, Saad F, Shore ND, De Giorgi U, Penson DF, Ferreira U, Efstathiou E, Madziarska K, Kolinsky MP, Cubero DIG, Noerby B, Zohren F, Lin X, Modelska K, Sugg J, Steinberg J, Hussain M; PROSPER Investigators. Sternberg CN, et al. N Engl J Med. 2020 Jun 4;382(23):2197-2206. doi: 10.1056/NEJMoa2003892. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469184 Clinical Trial.
Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities.
Maluf F, Soares A, Avanço G, Hada AL, Cardoso APG, Carneiro A, Herchenhorn D, Jardim DLF, Schutz FA, Kater FR, Pereira FMT, Monteiro FSM, Morbeck IAP, Reolon JFN, da Trindade KM, Andrade LMQDS, Nogueira LM, Furoni R, Natel RA, Dos Reis RB, Fogace RN, Souza VC. Maluf F, et al. Among authors: herchenhorn d. Int Braz J Urol. 2021 Mar-Apr;47(2):359-373. doi: 10.1590/S1677-5538.IBJU.2020.0249. Int Braz J Urol. 2021. PMID: 33284538 Free PMC article.
Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
Maluf FC, Pereira FMT, Silva AG, Dettino ALA, Cardoso APG, Sasse AS, Soares A, Kann AG, Herchenhorn D, Jardim DLF, Cortés DEL, Kater FR, Morbeck IAP, Reolon JFN, Rinck JA Jr, Zarbá JJ, Sade JP, da Trindade KM, Costa LAGA, Dos Santos LV, Maia MC, Siqueira MB, Gillessen S. Maluf FC, et al. Among authors: herchenhorn d. JCO Glob Oncol. 2021 Apr;7:559-571. doi: 10.1200/GO.20.00511. JCO Glob Oncol. 2021. PMID: 33856891 Free PMC article.
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415).
Maluf FC, Schutz FA, Cronemberger EH, Luz MA, Martins SPS, Muniz DQB, Bastos DA, Cárcano FM, Smaletz O, Soares A, Peixoto FA, Gomes AJ, Cruz FM, Franke FA, Herchenhorn D, Dos Santos TM, Fabricio VC, Gidekel R, Werutsky G, de Jesus RG, Souza VC, Fay AP. Maluf FC, et al. Among authors: herchenhorn d. Eur J Cancer. 2021 Oct 13;158:63-71. doi: 10.1016/j.ejca.2021.08.032. Online ahead of print. Eur J Cancer. 2021. PMID: 34655838 Free article.
"Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil".
Jardim DL, Gonçalves E Silva A, Pompeo ASFL, Sarkis AS, Cardoso APG, Sasse AD, Fay AP, Soares A, Pompeo ACL, Carneiro A, Kann AG, Fogassa C, De Freitas CH Junior, Chade DC, Herchenhorn D, De Almeida DVP, Da Rosa DAR, Wiermann EG, Schutz FAB, Kater FR, De Moura F, Korkes F, Meyer F, De Oliveira FNG, Sabino F, Almeida GL, Avanço G, Guimaraes GC, Lemos GC, Carvalhal GF, Kim H, Morbeck IP, Campagnari JC, Rinck JA Junior, Da Ponte JRT, Da Trindade KM, Atem L, Borges L, Nogueira LM, Batista LTEA, Maia MC, Sadi MV, Rocha MAA, Luz MA, Smaletz O, Lages PSM, Matuda RMK, Reis RBD, Indio RF, Fernandes RC, Cavallero SR, Souza VC, Busato W Jr, Alfer W Junior, Maluf F. Jardim DL, et al. Among authors: herchenhorn d. Clin Genitourin Cancer. 2023 Apr;21(2):e58-e69. doi: 10.1016/j.clgc.2022.09.005. Epub 2022 Sep 10. Clin Genitourin Cancer. 2023. PMID: 36266221 Free article.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Fiala O, Buti S, Takeshita H, Okada Y, Massari F, Palacios GA, Dionese M, Scagliarini S, Büttner T, Fornarini G, Myint ZW, Galli L, Souza VC, Pichler R, De Giorgi U, Quiroga MNG, Gilbert D, Popovic L, Grande E, Mammone G, Berardi R, Crabb SJ, Molina-Cerrillo J, Freitas M, Luz M, Iacovelli R, Calabrò F, Tural D, Atzori F, Küronya Z, Chiari R, Campos S, Caffo O, Fay AP, Kucharz J, Zucali PA, Rinck JA, Zeppellini A, Bastos DA, Aurilio G, Mota A, Trindade K, Ortega C, Sade JP, Rizzo M, Vau N, Giannatempo P, Barillas A, Monteiro FSM, Dauster B, Cattrini C, Nogueira L, de Carvalho Fernandes R, Seront E, Aceituno LG, Grillone F, Cutuli HJ, Fernandez M, Bassanelli M, Roviello G, Abahssain H, Procopio G, Milella M, Kopecky J, Martignetti A, Messina C, Caitano M, Inman E, Kanesvaran R, Herchenhorn D, Santini D, Manneh R, Bisonni R, Zakopoulou R, Mosca A, Morelli F, Maluf F, Soares A, Nunes F, Pinto A, Zgura A, Incorvaia L, Ansari J, Zabalza IO, Landmesser J, Rizzo A, Mollica V, Sorgentoni G, Battelli N, Porta C, Bellmunt J, Santoni M. Fiala O, et al. Among authors: herchenhorn d. Cancer Immunol Immunother. 2023 Nov;72(11):3665-3682. doi: 10.1007/s00262-023-03518-z. Epub 2023 Sep 7. Cancer Immunol Immunother. 2023. PMID: 37676282 Free PMC article.
43 results